# Teriparatide to denosumab switch: bone density at 4 years

Source: https://pepvault.app/research/teriparatide-data-switch-2015

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Teriparatide](https://pepvault.app/research#teriparatide)

Randomized trial · people

# Teriparatide then denosumab: spine density up 18.3% over 4 years

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this trial, the order mattered: going from teriparatide to denosumab kept bone density rising, while going from denosumab to teriparatide gave smaller gains at the hip and a loss at the wrist.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 77
- **Published:** 2015
- **Journal:** Lancet

## What they tested

The team set out to test how bone density changes when women with osteoporosis after menopause switch between teriparatide and denosumab.

## How the study was done

A randomized controlled extension of the DATA trial in 77 women with osteoporosis after menopause. After 24 months on teriparatide, denosumab or both, they switched treatments for 24 more months: teriparatide to denosumab, denosumab to teriparatide, or the combination to denosumab alone.

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Over 4 years, spine bone mineral density (BMD) rose 18.3% in the teriparatide to denosumab group, 14.0% in the denosumab to teriparatide group and 16.0% in the combination to denosumab group. These spine differences were not statistically significant. Total hip BMD rose 6.6% after teriparatide to denosumab, compared with 2.8% after denosumab to teriparatide, and 8.6% in the combination to denosumab group. Wrist (radius) BMD was unchanged at 0.0% after teriparatide to denosumab, fell 1.8% after denosumab to teriparatide, and rose 2.8% in the combination to denosumab group.

## What it doesn’t show

The groups were small, with 23 to 27 women each, and the study measured bone density and bone turnover markers, not fractures. It was funded in part by Amgen and Eli Lilly.

## The paper

Leder et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet. 2015.

- [PubMed (PMID 26144908)](https://pubmed.ncbi.nlm.nih.gov/26144908/)
- [The paper (DOI 10.1016/S0140-6736(15)61120-5)](https://doi.org/10.1016/S0140-6736%2815%2961120-5)
- [ClinicalTrials.gov (NCT00926380)](https://clinicaltrials.gov/study/NCT00926380)

## The compound

- [Teriparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## More studies on Teriparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024) Meta-analysis · people · 2024
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Teriparatide: more bony union at 6 months than zoledronate after PLIF](https://pepvault.app/research/teriparatide-xiong-2022) Randomized trial · people · 2022
- [Teriparatide: 45.4% of jaw osteonecrosis lesions resolved by 52 weeks](https://pepvault.app/research/teriparatide-sim-2020) Randomized trial · people · 2020
- [Teriparatide: fewer new vertebral fractures than risedronate in VERO](https://pepvault.app/research/teriparatide-vero-2018) Randomized trial · people · 2018
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

## The library

- [Teriparatide](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
